本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cullinan Therapeutics

20.59
-0.4100-1.95%
盤後21.110.5200+2.53%19:46 EDT
成交量:109.06萬
成交額:2,242.44萬
市值:13.25億
市盈率:-5.94
高:21.34
開:21.16
低:20.10
收:21.00
52周最高:23.19
52周最低:5.68
股本:6,435.47萬
流通股本:4,808.28萬
量比:1.32
換手率:2.27%
股息:- -
股息率:- -
每股收益(TTM):-3.4680
每股收益(LYR):-3.7236
淨資產收益率:-50.30%
總資產收益率:-31.36%
市淨率:4.12
市盈率(LYR):-5.53

資料載入中...

2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/29

重要事件披露

Form 8-K - Current report
2024/04/24

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/16

重要事件披露

Form 8-K - Current report
2024/03/14

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/14

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/14

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]